Patent · US Active

Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors

US7605154B2 · kind B2 · utility

2Cited by

0References

5Claims

0Family size

Assignee

Janssen Pharmaceutica NA · BE

Inventors

Eva Binnun · Boston, US
Peter J. Connolly · New Providence, US
Sigmond Johnson · Flemington, US
Ronghui Lin · Ambler, US
Steven A. Middleton · Flemington, US
Sandra J. Moreno-Mazza · Colonia, US
Niranjan B. Pandey · White Marsh, US
Steven K. Wetter · Flemington, US

Key dates

Filing date	Aug 2, 2006
Grant date	Oct 20, 2009
Priority date	—
Expiry date	Mar 24, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to novel thiazolopyrimidine compounds of Formula (I) or a form or composition thereofand the use thereof as inhibitors of ATP-protein kinase interactions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.